# A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation

> **NCT05921734** · NA · COMPLETED · sponsor: **Shanghai Chest Hospital** · enrollment: 480 (actual)

## Conditions studied

- Atrial Fibrillation
- Cathter Ablation
- Endpoint

## Interventions

- **PROCEDURE:** AF-termination Group
- **PROCEDURE:** Prespecified-ablation Group

## Key facts

- **NCT ID:** NCT05921734
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 480 (ACTUAL)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05921734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05921734, "A Randomized Controlled Study of Ablation Pursuing Atrial Fibrillation Termination as a Procedural Endpoint in Patients With Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05921734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*